# Uwe Platzbecker

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/uwe-platzbecker/

## Facts

| Field | Value |
| --- | --- |
| Citations | 39,877 |
| Field | Acute Myeloid Leukemia Research |
| h-index | 88 |
| i10-index | 499 |
| Last Known Institution | National Center for Tumor Diseases |
| OpenAlex ID | https://openalex.org/A5079124367 |
| ORCID iD | https://orcid.org/0000-0003-1863-3239 |
| Works | 1,511 |

## Researcher papers

- [Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis](https://scholariq.org/papers/analysis-of-flt3-activating-mutations-in-979-patients-with-acute-myelogenous/)
- [Molecular International Prognostic Scoring System for Myelodysplastic Syndromes](https://scholariq.org/papers/molecular-international-prognostic-scoring-system-for-myelodysplastic-syndromes/)
- [Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial](https://scholariq.org/papers/azacitidine-for-treatment-of-imminent-relapse-in-mds-or-aml-patients-after/)
- [Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents](https://scholariq.org/papers/randomized-phase-iii-study-of-lenalidomide-versus-placebo-in-rbc-transfusion/)
- [Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms](https://scholariq.org/papers/phase-i-first-in-human-dose-escalation-study-of-the-oral-sf3b1-modulator-h3b/)
- [A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial](https://scholariq.org/papers/a-novel-prognostic-model-in-elderly-patients-with-acute-myeloid-leukemia-results/)

## Researcher topics

- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Myeloproliferative Neoplasms: Diagnosis and Treatment](https://scholariq.org/topics/myeloproliferative-neoplasms-diagnosis-and-treatment/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)

## Researcher university

- [National Center for Tumor Diseases](https://scholariq.org/institutions/national-center-for-tumor-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.